2-Methylpyridine-4-boronic acid → (S)-6-(2-(1,1-dioxo-isothiazolidin-2-yl)ethyl)-3-((S)-1-(4-(2-methylpyridin-4-yl)phenyl)ethyl)-6-phenyl-1,3-oxazinan-2-one

HRID 1046166

Reaktionsgleichung

Reaktionsgleichung von HRID 1046166
Br[C:2]1[CH:7]=[CH:6][C:5]([C@@H:8]([N:10]2[CH2:15][CH2:14][C@:13]([CH2:22][CH2:23][N:24]3[CH2:28][CH2:27][CH2:26][S:25]3(=[O:30])=[O:29])([C:16]3[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=3)[O:12][C:11]2=[O:31])[CH3:9])=[CH:4][CH:3]=1.[CH3:32][C:33]1[CH:38]=[C:37](B(O)O)[CH:36]=[CH:35][N:34]=1>>[O:29]=[S:25]1(=[O:30])[CH2:26][CH2:27][CH2:28][N:24]1[CH2:23][CH2:22][C@@:13]1([C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][CH:17]=2)[O:12][C:11](=[O:31])[N:10]([C@H:8]([C:5]2[CH:6]=[CH:7][C:2]([C:37]3[CH:36]=[CH:35][N:34]=[C:33]([CH3:32])[CH:38]=3)=[CH:3][CH:4]=2)[CH3:9])[CH2:15][CH2:14]1

Komponenten

3

Edukt 2

HCID 41926642-Methylpyridine-4-boronic acidHCID 59635736(S)-3-((S)-1-(4-bromophenyl)ethyl)-6-(2-(1,1-dioxo-isothiazolidin-2-yl)ethyl)-6-phenyl-1,3-oxazinan-2-one

Produkt 1

HCID 58109173(S)-6-(2-(1,1-dioxo-isothiazolidin-2-yl)ethyl)-3-((S)-1-(4-(2-methylpyridin-4-yl)phenyl)ethyl)-6-phenyl-1,3-oxazinan-2-one

Versuchsvorschrift

The title compound was prepared from (S)-3-((S)-1-(4-bromophenyl)ethyl)-6-(2-(1,1-dioxo-isothiazolidin-2-yl)ethyl)-6-phenyl-1,3-oxazinan-2-one and 2-methylpyridine-4-boronic acid following a procedure analogous to that described in Example 1 Step 2. LC-MS Method 2 tR=0.984, m/z=520.1; 1H NMR (CDCl3) 1.52 (d, 3H), 2.11-2.29 (m, 5H), 2.32 (m, 2H), 2.81 (s, 3H), 2.83-2.96 (m, 2H), 2.98-3.08 (m, 3H), 3.11-3.22 (m, 2H), 5.67 (m, 1H), 7.06 (d, 2H), 7.24-7.36 (m, 5H), 7.38 (d, 2H), 7.61 (s, 1H), 7.69 (m, 1H), 8.73 (d, 1H).

Quellen und Nachweise

ORD-Eintrag
ord-dbec87ad4af944cfa14ece34fb0ae6c6
Quelldatensatz
uspto-grants-2013_10
Patentnummer
US08569292B2

Verknüpfte Notizen

Wird geladen…